Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of novel mutations in Japanese ovarian clear cell carcinoma patients using optimized targeted NGS for clinical diagnosis.

Gynecologic oncology - 1 Feb 2017

Maru Yoshiaki, Tanaka Naotake, Ohira Miki, Itami Makiko, Hippo Yoshitaka, Nagase Hiroki

Abstract excerpt

OBJECTIVE: Ovarian clear cell carcinoma (OCCC) is an aggressive ovarian cancer with a higher frequency in Japan and often becomes chemorefractory disease. Reliable genetic diagnosis is essential to affirm the success of precision medicine for OCCC treatment. The aim of this study is, therefore, to identify novel mutations in OCCCs and develop a feasible clinical next generation sequencing (NGS) approach using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Clear Cell
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CTNNB1 gene

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Share to Ovarian cancer diagnosis and treatment

Share to Ovarian Neoplasms

Share to Paraffin Embedding

Source

Identifiers

PMID: 27939411
DOI: 10.1016/j.ygyno.2016.11.045

Genes

CSMD3
CTNNB1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of novel mutations in Japanese ovarian clear cell carcinoma patients using optimized targeted NGS for clinical diagnosis.PMID 27939411Read ↗

Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing.Semantic proximity Read ↗

Genomic landscape of ovarian clear cell carcinoma via whole exome sequencing.Semantic proximity Read ↗

Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patientsSemantic proximity Read ↗

A comprehensive molecular analysis of 113 primary ovarian clear cell carcinomas reveals common therapeutically significant aberrationsSemantic proximity Read ↗

Whole-exome mutational landscape and molecular marker study in mucinous and clear cell ovarian cancer cell lines 3AO and ES2.Semantic proximity Read ↗

Genomic characterization of Chinese ovarian clear cell carcinoma identifies driver genes by whole exome sequencing.Semantic proximity Read ↗

Genomic profiling of ovarian clear cell carcinoma in Chinese patients reveals potential prognostic biomarkers for survival.Semantic proximity Read ↗

Identification of novel mutations of ovarian cancer-related genes from RNA-sequencing data for Japanese epithelial ovarian cancer patients.Semantic proximity Read ↗

Exome Sequencing Landscape Analysis in Ovarian Clear Cell Carcinoma Shed Light on Key Chromosomal Regions and Mutation Gene Networks.Semantic proximity Read ↗

Review the progression of ovarian clear cell carcinoma from the perspective of genomics and epigenomicsSemantic proximity Read ↗

Somatic mutation of targeted sequencing identifies risk stratification in advanced ovarian clear cell carcinoma.Semantic proximity Read ↗

Japanese version of The Cancer Genome Atlas, JCGA, established using fresh frozen tumors obtained from 5143 cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.